CyBio AG, through its subsidiaries, engages in the development, manufacture, and marketing of laboratory systems and equipment, and related software.

Its liquid handling products include pipetting systems, dispensing systems, genomics and proteomics workstations, and entry products; plate handling products that comprise screen-machines, cellight for bioluminescence screening, replicators, and print work stations; and plate reading products, including luminescence readers. The company also provides data handling products that consist of controls, schedulers, and plate tracking products. In addition, it provides Lumax Control software that enables imaging analysis and provides integration into screening systems; and CyBi-WBMS, a Web-based remote monitoring of lab automation systems for instrument training and remote-based service diagnostics. The company also provides accessories, which include adapters, barcode readers, pin tools, reservoirs, peristaltic pumps, tip wash stations, tip changers, stackers, and transport systems, as well as consumables, including tips and tip trays. The company’s products are used in drug discovery, plate production, genomics, and proteomics. The company operates in the United States, Europe, and Asia. CyBio was founded in 1990 and is headquartered in Jena, Germany.